News
Zacks Investment Research on MSN
Why Amgen (AMGN) is a Top Value Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Amgen Inc. has seen a notable increase in its stock holdings, with Legacy Private Trust Co. boosting its stake by 13.6%. The ...
Amgen Inc. (NASDAQ: AMGN) is one of the best drug stocks to buy right now. Amgen Inc. (NASDAQ:AMGN) reported its fiscal Q2 ...
In a phase 1b trial, tarlatamab plus an anti-PD-L1 in first-line maintenance achieves a median survival of more than 2 years ...
Amgen Inc. recently dazzled the biotech community with promising Phase 3 results for its new treatment, rocatinlimab. This ...
Amgen, a Thousand Oaks-based biotechnology giant, plans to invest $600 million in a center for science and innovation at its ...
Amgen and Gilead Sciences announce investments in California, reinforcing the state's role as a life sciences leader.
Prevent Blindness participates in global “World Sight Day” initiative with a variety of eye health events and programs offered free to the public.
Oracle sent its stock soaring 36%, according to Reuters, adding about $234 billion to its market value last week after unveiling its quarterly financial report and announcing a new AI cloud strategy.
Zacks Investment Research on MSN
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...
Thousand Oaks-based biotech giant Amgen Inc. announced this month that it plans to invest more than $600 million in a new, ...
Amgen trades below historical multiples despite strong Q2 results, a robust pipeline, and a 3.4% yield, offering value. Check ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results